Pharmacoeconomic Analysis of Amphotericin B Lipid Complex versus Liposomal Amphotericin B in the Treatment of Fungal Infections

被引：0
|
作者：
Joseph L. Kuti
Srividya Kotapati
Peter Williams
Blair Capitano
Charles H. Nightingale
David P. Nicolau
机构：
[1] Hartford Hospital,Center for Anti
[2] University of Pittsburgh,Infective Research and Development
[3] Hartford Hospital,School of Pharmacy
[4] Hartford Hospital,Office of Research Administration
来源：
PharmacoEconomics | 2004年 / 22卷
关键词：
Invasive Aspergillosis; Liposomal Amphotericin; Pharmacoeconomic Analysis; Lipid Formulation; Bone Marrow Transplant Recipient;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Background: Potential differences in toxicity, potency and acquisition price among the liposomal amphotericin B formulations makes it unclear which agent is less costly when total resource consumption and treatment-associated costs are considered.
引用
收藏
页码：301 / 310
页数：9
相关论文
共 50 条
  • [1] Pharmacoeconomic analysis of amphotericin B lipid complex versus liposomal amphotericin B in the treatment of fungal infections
    Kuti, JL
    Kotapati, S
    Williams, P
    Capitano, B
    Nightingale, CH
    Nicolau, DP
    PHARMACOECONOMICS, 2004, 22 (05) : 301 - 310
  • [2] Budget impact analysis of liposomal amphotericin B and amphotericin B lipid complex in the treatment of invasive fungal infections in the United States
    Yang H.
    Chaudhari P.
    Zhou Z.-Y.
    Wu E.Q.
    Patel C.
    Horn D.L.
    Applied Health Economics and Health Policy, 2014, 12 (1) : 85 - 93
  • [3] BUDGET IMPACT ANALYSIS OF LIPOSOMAL AMPHOTERICIN B VERSUS AMPHOTERICIN B LIPID COMPLEX FOR THE TREATMENT OF INVASIVE FUNGAL INFECTIONS IN A TERTIARY HOSPITAL IN THE KINGDOM OF SAUDI ARABIA
    AlJedai, A.
    AlRaddadi, B.
    Vemer, P.
    Awad, N.
    Safwat, M.
    Mansour, E.
    Hanna, E.
    VALUE IN HEALTH, 2018, 21 : S223 - S223
  • [4] Pharmacoeconomic evaluation of caspofungin versus liposomal amphotericin B in empirical treatment of invasive fungal infections in Turkey
    Turner, S. J.
    Senol, E.
    Kara, A.
    Al-Badriyeh, D.
    Kong, D. C. M.
    Dinleyici, E. C.
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2013, 42 (03) : 276 - 280
  • [5] BUDGET IMPACT ANALYSIS OF LIPOSOMAL AMPHOTERICIN B AND AMPHOTERICIN B LIPID COMPLEX FOR TREATING INVASIVE FUNGAL INFECTIONS IN HOSPITALIZED PATIENTS
    Chaudhari, P.
    Yang, H.
    Zhou, Z. Y.
    Patel, C.
    Wu, E. Q.
    VALUE IN HEALTH, 2013, 16 (03) : A83 - A84
  • [6] Amphotericin B lipid complex for the treatment of invasive fungal infections
    Linden, PK
    EXPERT OPINION ON PHARMACOTHERAPY, 2003, 4 (11) : 2099 - 2110
  • [7] Liposomal amphotericin B treatment for neonatal fungal infections
    Scarcella, A
    Pasquariello, MB
    Giugliano, B
    Vendemmia, M
    De Lucia, A
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1998, 17 (02) : 146 - 148
  • [8] Pharmacoeconomic analysis of liposomal amphotericin B versus conventional amphotericin B in the empirical treatment of persistently febrile neutropenic patients
    Cagnoni, PJ
    Walsh, TJ
    Prendergast, MM
    Bodensteiner, D
    Hiemenz, S
    Greenberg, RN
    Arndt, CAS
    Schuster, M
    Seibel, N
    Yeldandi, V
    Tong, KB
    JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (12) : 2476 - 2483
  • [9] LIPOSOMAL AMPHOTERICIN-B IN THE TREATMENT OF FUNGAL-INFECTIONS
    LOPEZBERESTEIN, G
    ANNALS OF INTERNAL MEDICINE, 1986, 105 (01) : 130 - 131
  • [10] Retrospective analysis of the dosage of amphotericin B lipid complex for the treatment of invasive fungal infections
    Linden, P
    Lee, L
    Walsh, TJ
    PHARMACOTHERAPY, 1999, 19 (11): : 1261 - 1268
12345